Newest Issue is Out. Get your exclusive copy today.

Subscribe for Free

SUEZ Water Technologies & solutions

Natural Intelligence

OCULAR DRUG DELIVERY PERSPECTIVE

MULTI-FACETED GATEWAYS FOR DRUG REPURPOSING

NANO-BASED DRUG DELIVERY

Advanced Computational Drug Discovery Tools

CLINICAL TRIALS IN A PETRI DISH

PATIENT ENROLMENT

EMERGING TECHNOLOGIES FOR PARTICLE ENGINEERING

INTRAPERITONEAL SUSTAINED - RELEASE CHEMOTHERAPY FOR REFRACTORY OVARIAN CANCER

The Cyber-Physical Security of Pharmaceutical Manufacturing Processes

Get instant access to latest e-book

LATEST NEWSRead more...

27

May 2020

Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb

Repare Therapeutics Inc Repare a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in genetically defined patient populations today announced it has entered into an exclusive worldwide research collaboration with Br...

27

May 2020

ArcherDX Announces Strategic Collaboration with AstraZeneca

ArcherDX Inc announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase clinical trials for AstraZenecas targeted immunooncology therapeutics

26

May 2020

Oncodesign and HitGen Announce a Strategic Partnership in Integrated Drug Discovery Services (IDDS)

ONCODESIGN announced the start of a worldwide strategic alliance in Integrated Drug Discovery Services for the identification and progression of new chemical entities spanning from Hit finding up to preparation of the Investigational New Drug filing

26

May 2020

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies

Tavotek Biotherapeutics a biotech company which develops novel biologics for autoimmune diseases and oncology announced that it has entered into a research agreement with Genmab AS of Denmark to create and develop bispecific antibodies using Genmabs DuoBody technology platform against disease releva...

25

May 2020

FDA approves Takeda's ALUNBRIG ® (brigatinib) as a first-line treatment for patients with rare and severe forms of lung cancer

Takeda Pharmaceutical Company Limited TSE NYSE TAK announced today that the US Food and Drug Administration FDA is approved for ALUNBRIG Brigatinib for adult patients with anaplastic lymphoma kinase ALK positive metastatic nonsmall cell lung cancer NSCLC which was diagnosed by an FDAapproved test...

23

May 2020

AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly

AbCellera announced that it has entered into a multiyear strategic research collaboration and license agreement with Eli Lilly and Company Lilly on the discovery of antibodies for up to nine Lillyselected therapeutic targets Lilly will have the rights to develop and commercialize therapeutic product...

22

May 2020

Kleo Pharmaceuticals and Celularity Enter into Research Collaboration

Kleo Pharmaceuticals Inc a leading company in the field of developing nextgeneration fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics and Celularity Inc a leading developer of allogeneic or offtheshelf natural killer NK cell therapies today announced a pr...

press releasesRead more...

27

May 2020

Protara Therapeutics Receives Fast Track Designation from U.S. FDA for Intravenous Choline Chloride for the Treatment of Intestinal Failure Associated Liver Disease

Protara Therapeutics Inc a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs announced that the US Food and Drug Administration FDA has granted Fast Track designation to Intravenous IV Choline Chloride for the treatment of intestinal failureass...

27

May 2020

Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

Ceapro Inc a growthstage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries today announced it has entered into an additional research project expanding on the ongoing collaboration with McMaster University to develop a...

26

May 2020

SeraNovo Enters into a Second License Agreement with Carna Biosciences for Development of Oral Formulation of Carna’s Kinase Inhibitor

SeraNovo BV announced that it has signed a second License Agreement with Carna Biosciences Inc a company engaged in the drug development of kinase inhibitors Under the agreement the companies will expand their existing collaboration and jointly develop an oral formulation of a new active ingredient...

26

May 2020

Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology autoimmune metabolic and other major diseases today announced that the first patient has been successfully dosed in a Phase clinical trial...

25

May 2020

Algernon Submits Investigational New Drug (IND) Application with U.S. FDA for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil for COVID-19

Algernon Pharmaceuticals Inc a clinical stage pharmaceutical development company is pleased to announce that it has submitted an Investigational New Drug IND application with the US FDA for its planned multinational Phase b study of its repurposed drug NP Ifenprodil as a potential therapeutic treatm...

23

May 2020

Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia

Zealand Pharma AS a biotechnology company changing lives with innovative peptidebased medicines announced that the US Food and Drug Administration FDA has accepted for filing the companys New Drug Application NDA for the dasiglucagon HypoPal Rescue Pen for the treatment of hypoglycemia in people wi...

22

May 2020

Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Approval

Aquestive Therapeutics Inc a pharmaceutical company focused on developing and commercializing differentiated products that address patients unmet needs and solve therapeutic problems today announced plans to advance its strategy to monetize the anticipated royalties associated with Sunovion Pharmace...

EventsRead more...

27 - 28

May 2020

Pathology 2020

Dublin

28 - 28

May 2020

11th Annual Clinical Trials Summit 2020

Virtue Insight
Kohinoor Continental Hotel

02 - 22

Jun 2020

World Congress on Antibiotics 2020

Zurich

03 - 04

Jun 2020

Parkinson's and Movement Disorders

Pulsus Conference
Vienna

08 - 09

Jun 2020

Neuroscience and Neurological Disorders

Pulsus
London,

10 - 11

Jun 2020

ENT Conference 2020

Frankfurt

10 - 11

Jun 2020

Pharmacology and Pharmaceutical Research

Hall A

15 - 17

Jun 2020

Cold Chain Global Forum Canada 2020

Toronto

Capsugel® capsules. Often imitated. Never duplicated.

KNOWLEDGE BANK

Interviews

Porton Pharma Solutions and Codexis Launch Global Partnership

PARTNERSHIP
Codexis Inc and Porton Pharma Solutions Ltd announce a strategic collaboration to deploy Codexis worldleading biocatalyst technology within Portons global custom intermediate and active pharmaceutical ingredients API development and manufacturing bus...

Articles

Bio-Inspired Nanomedicine An Emerging Trend For Drug Targeting Into Cancer Cells

The mortality rate increases daytoday due to most vulnerable disease cancer universally and current therapeutic mitigation bears high levels of diversity and complexity in therapeutic regime The systemic application of chemotherapeutic agents often accompanied with serious side and adverse effects along with normal cell toxicity

Research Insights

Open For Collaboration: An Academic Platform For Drug Discovery And Development At Scilifelab

Abstract Swedish pharmaceutical industry and research Being a small country with only million inhabitants Sweden has a proud history of successful organic growth of its pharmaceutical industry with companies such as Kabi the first company to license Genentechs recombinant DNA technology later overtaken by Pharmacia subs

Case Studies

Effects Of Low-dose Ibuprofen Supplementation And Resistance Training On Bone And Muscle In Postmenopausal Women: A Randomized & Controlled Trial

Abstract Purpose To compare the effects of nine months of exercise training and ibuprofen supplementation given immediately after exercise sessions on bone and muscle in postmenopausal women Methods In a doubleblin

Techno Trends

UIC's Scientists Develop a Novel Device to Screen Advanced Crystalline Materials

Researchers and scientists at the University of Illinois at Chicago and AbbVie Inc developed a novel device to screen and test formation of drug substanceActive Pharmaceutical Ingredient API

White Papers

Considerations In Purchasing A Laboratory Information Management System (LIMS)

Summary Many scientific enterprises find themselves in need of a Laboratory Information Management System LIMS to replace an incumbent system whether an existing commercial application an amalgam of systems or an inhouse solution Once the decision has been made the selection and deployment of a new LIMS should move quickly and decisively This white pap

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

DRUG REGULATIONS AND PHARMA COMPANIES’ PLAN OF COMPLIANCE

The Pharmaceutical industry has been growing in parallel to human evolution

RESEARCH DEVELOPMENT

Medicines Management and Drug Delivery

There is a rising opportunity for the pharma industry to consider developing products and administration devices for older age population The proporti...

CLINICAL TRIALS

Barriers Preventing Clinical Trial Software Development

Back in August of in the Wall Street Journal Marc Andressen the famous venture capitalist wrote a now classic editorial in which he predicted that so...

MANUFACTURING

CONTINUOUS MANUFACTURING

The pharmaceutical industry is undergoing a transformation It is transitioning from a closed internal integrated discovery and development business mo...

Information Technology

PHARMA SUPPLY CHAIN INTELLIGENCE

New technologies advanced software systems and the integration of IT within the pharma supply chain are increasingly playing a pivotal part in protect...

EXPERT Talk

PHARMA LOGISTICS TRENDS

Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...

SUEZ Water Technologies & solutions

Natural Intelligence

OCULAR DRUG DELIVERY PERSPECTIVE

MULTI-FACETED GATEWAYS FOR DRUG REPURPOSING

NANO-BASED DRUG DELIVERY

Advanced Computational Drug Discovery Tools

CLINICAL TRIALS IN A PETRI DISH

PATIENT ENROLMENT

EMERGING TECHNOLOGIES FOR PARTICLE ENGINEERING

INTRAPERITONEAL SUSTAINED - RELEASE CHEMOTHERAPY FOR REFRACTORY OVARIAN CANCER

The Cyber-Physical Security of Pharmaceutical Manufacturing Processes

Get instant access to latest e-book

LATEST NEWSRead more...

27

Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb

27

ArcherDX Announces Strategic Collaboration with AstraZeneca

26

Oncodesign and HitGen Announce a Strategic Partnership in Integrated Drug Discovery Services (IDDS)

26

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies

25

FDA approves Takeda's ALUNBRIG ® (brigatinib) as a first-line treatment for patients with rare and severe forms of lung cancer

23

AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly

22

Kleo Pharmaceuticals and Celularity Enter into Research Collaboration

press releasesRead more...

27

Protara Therapeutics Receives Fast Track Designation from U.S. FDA for Intravenous Choline Chloride for the Treatment of Intestinal Failure Associated Liver Disease

27

Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

26

SeraNovo Enters into a Second License Agreement with Carna Biosciences for Development of Oral Formulation of Carna’s Kinase Inhibitor

26

Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China

25

Algernon Submits Investigational New Drug (IND) Application with U.S. FDA for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil for COVID-19

23

Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia

22

Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Approval

EventsRead more...

27 - 28

Pathology 2020

28 - 28

11th Annual Clinical Trials Summit 2020

02 - 22

World Congress on Antibiotics 2020

03 - 04

Parkinson's and Movement Disorders

08 - 09

Neuroscience and Neurological Disorders

10 - 11

ENT Conference 2020

10 - 11

Pharmacology and Pharmaceutical Research

15 - 17

Cold Chain Global Forum Canada 2020

Advertisements

TOP ARTICLES

1

A BITTER PILL: Exploring the Realm of Drug Counterfeiting

2

Quality by Design Applications in Pharmaceutical Product Development

3

A Concise Treatise on Hard and Soft Nanomaterials for Drug Delivery

4

When Orphan Drugs Make All the Difference

5

MicroRNA (miRNA) in Nanostructure Lipid Carriers based Tumor Gene Therapy

KNOWLEDGE BANK

Porton Pharma Solutions and Codexis Launch Global Partnership

Bio-Inspired Nanomedicine An Emerging Trend For Drug Targeting Into Cancer Cells

Open For Collaboration: An Academic Platform For Drug Discovery And Development At Scilifelab

Effects Of Low-dose Ibuprofen Supplementation And Resistance Training On Bone And Muscle In Postmenopausal Women: A Randomized & Controlled Trial

UIC's Scientists Develop a Novel Device to Screen Advanced Crystalline Materials

Considerations In Purchasing A Laboratory Information Management System (LIMS)

Advisory Board

EDITORIAL SECTION